Prostate cancer - TRAIL is worth a trial
Links shared publicly online about this topic.
- 858total visits
Prostate cancer - TRAIL is worth a trial
View full resource at news-medical.net
Tags: Cancer, Prostate Cancer, Prostate, Protein, Medical School, Men's Health, Urology, Medical
Most Recently Shared on September 21, 2010 at 4:36 pm By:
Prostate Cancer: Prostate cancer - TRAIL is worth a trial: One of the human body's protective mechanisms initiated... http://bit.ly/aIJW96
Also Shared By:
Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial : The Lancet Oncology
thelancet.com — “Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. By - Ravi A Madan MD, Mahsa Mohebtash MD, ...” View full resource at thelancet.com
Most Recently Shared on May 1, 2012 at 5:37 pm By:
[Articles] Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resist... http://t.co/L9G879WO
Prostate cancer surgery 'has no significant survival benefit', study suggests - Health News, Health - Independent.ie
independent.ie — “THOUSANDS of men could have undergone painful surgery to treat prostate cancer for little or no benefit, a study has suggested.” View full resource at independent.ie
Most Recently Shared on April 30, 2012 at 1:01 pm By:
Dr Steven Tucker Oncologist, Physician, Doctor, and Internist
PIVOT trial. Prostate cancer. No benefit for surgery vs. watchful waiting. http://t.co/ebru2SwO
BBC News - New prostate cancer treatment may reduce side-effects
bbc.co.uk — “A new technique to combat early prostate cancer may have far fewer side-effects than standard treatments, researchers say.” View full resource at bbc.co.uk
Most Recently Shared on April 17, 2012 at 12:28 am By:
Prostate trial 'very encouraging' http://t.co/TpujBk5A
High cancer treatment costs in the US – are they worth it? Study explores
news-medical.net — “Healthcare in the United States is costlier than care in other countries. A new analysis suggests that the cost may be worth it at least when it comes to cancer care. Americans may pay more for cancer treatment, but they also live longer after diagnosis — getting a benefit that offsets their higher health expenses the study says.” View full resource at news-medical.net
Most Recently Shared on April 10, 2012 at 10:53 pm By:
High cancer treatment costs in the US – are they worth it? Study explores: Healthcare in the United States is co... http://t.co/ceUyu9x1
Galeterone Shown To Be Safe, Effective Against Prostate Cancer In Phase I Trial
medicalnewstoday.com — “Patients with castration-resistant prostate cancer had limited side effects and in many cases a drop in prostate-specific antigen expression with galeterone (TOK-001), a small-molecule oral drug,” View full resource at medicalnewstoday.com
Most Recently Shared on April 3, 2012 at 8:05 am By:
Galeterone Shown To Be Safe, Effective Against Prostate Cancer In Phase I Trial http://t.co/ZL7aItQ2 #prostate
Prostate cancer patients given hope by new 'triple-whammy' drug | Science | The Observer
guardian.co.uk — “Trials of galeterone record early success in treatment of advanced stage tumours” View full resource at guardian.co.uk
Most Recently Shared on April 3, 2012 at 12:27 am By:
Dr. P. D Tapp PhD, Doctor, and Health Executive
Prostate cancer patients given hope by new 'triple-whammy' drug. http://t.co/EMhnXuHJ
Trial of bevacizumab add-on therapy in advanced prostate cancer negative - The Doctor's Channel
thedoctorschannel.com — “NEW YORK (Reuters Health) – The addition of bevacizumab (Avastin; Genentech/Roche) to the standard docetaxel and prednisone in men with progressive metastatic castration-resistant prostate cancer (mCRPC) did not improve overall survival and was associated with greater toxicity...” View full resource at thedoctorschannel.com
Most Recently Shared on March 29, 2012 at 10:37 pm By:
Dr Michael Banks - The Doctor's Channel Health Site
Are there any benefits to taking bevacizumab in cases of advanced prostate cancer? - From Reuters Health/TDC http://t.co/ZrZ76DEN #oncology
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial : The Lancet
thelancet.com — “Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial. By - Prof, Dr Neil E Fleshner FRCSC, Prof M Scott Lucia MD, Blair Egerdie FRCSC, ...” View full resource at thelancet.com
Most Recently Shared on March 24, 2012 at 5:36 am By:
[Articles] Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-con... http://t.co/zJKW2Mpk
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial : The Lancet
thelancet.com — “Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial. By - Prof, Dr Neil E Fleshner FRCSC, Prof M Scott Lucia MD, Blair Egerdie FRCSC, ...” View full resource at thelancet.com
Most Recently Shared on March 23, 2012 at 4:57 pm By:
Alvin B. Lin Physician, Doctor, Family Medicine Doctor, and Geriatrician
#Dutasteride doesn't affect muscle mass but it may slow progression of low risk #prostatecancer #prostate #cancer http://t.co/ruUO3xzD
ingentaconnect Is using PHI for prostate cancer diagnosis in Europe worth it?
ingentaconnect.com — “ingentaconnect Is using PHI for prostate cancer diagnosis in Europe worth it?” View full resource at ingentaconnect.com
Most Recently Shared on March 22, 2012 at 5:44 am By:
Is using PHI for prostate cancer diagnosis in Europe worth it?: (Source: PharmacoEconomics and Outcomes News) http://t.co/fkUOfhEA
Important News Briefs: New Data Reported in Prostate, Bladder, and Kidney Cancers - The ASCO Post
ascopost.com — “Important News Briefs: New Data Reported in Prostate, Bladder, and Kidney Cancers - The ASCO Post” View full resource at ascopost.com
Most Recently Shared on March 20, 2012 at 1:22 pm By:
The ASCO Post Hematology, Oncology, and Health Magazine
New Data from GU Cancers Symposium: Exercise & #ProstateCancer, TKIs in #KidneyCancer, Secondary Analysis of AXIS Trial http://t.co/BztbCHca
Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial - Sutcliffe - 2012 - BJU International - Wiley Online Library
onlinelibrary.wiley.com — “Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial - Sutcliffe - 2012 - BJU International - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on March 20, 2012 at 12:40 pm By:
Non‐steroidal anti‐inflammatory drug use and the risk of benign prostatic hyperplasia‐related outcomes and noctu... http://t.co/LwqwfB7R
Medical News:PSA Testing Still Has Value, Trial Suggests - in Oncology/Hematology, Prostate Cancer from MedPage Today
medpagetoday.com — “Medical News:PSA Testing Still Has Value, Trial Suggests - in Oncology/Hematology, Prostate Cancer from MedPage Today” View full resource at medpagetoday.com
Most Recently Shared on March 16, 2012 at 5:40 pm By:
Dr. Steven Z. Kussin Internist, Gastroenterologist, Physician, and Doctor
There is still reason to discuss PSAs although the US Preventative Task Force Service says 'don't bother'. Our... http://t.co/HBbKC2k8
'Unanswered questions' over PSA prostate screening despite 11-year follow-up of trial : Cancer Research UK
info.cancerresearchuk.org — “A wide-ranging European study has failed to establish whether the benefits of prostate cancer screening outweigh the risks, despite showing that it can reduce death rates from the disease.” View full resource at info.cancerresearchuk.org
Most Recently Shared on March 15, 2012 at 4:10 pm By:
Cancer Research UK Health Organization
News: 'Unanswered questions' over PSA prostate screening despite 11-year follow-up of trial http://t.co/ANIls73i
Advertisement
News-Medical.Net
@NewsMedical
High cancer treatment costs in the US – are they worth it? Study explores: Healthcare in the United States is co... http://t.co/ceUyu9x1
1 year ago...